Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6242027 | Respiratory Medicine | 2014 | 7 Pages |
Abstract
ASA status was significantly different by race. Those with anti-Jo1 antibodies had worse lung function and CT scores over time compared to those without detectable antisynthetase antibodies. Further prospective study in a larger cohort is needed to determine whether these apparent antibody-specific differences in demographics and manifestations of disease translate into meaningful disparities in clinical outcomes.
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
C. Johnson, G.R. Connors, J. Oaks, S. Han, A. Truong, B. Richardson, N. Lechtzin, A.L. Mammen, L. Casciola-Rosen, L. Christopher-Stine, S.K. Danoff,